Table 1.
No. | Str. | R2 or XR3 | Inh (%)a |
---|---|---|---|
123 | A | NH2 | 100 |
2 | A | H | 3 |
3 | A | NHMe | 32 |
4 | A | NMe2 | 60 |
5 | A | NHCONH2 | 14 |
6 | B | O-i-Pr | 100 |
7 | B | 57 | |
8 | B | 49 | |
9 | B | OPh | 48 |
10 | B | OCH2Ph | 100 |
11 | B | OCH2Ph-2-Me | 64 |
12 | B | OCH2Ph-3-Me | 67 |
13 | B | OCH2Ph-4-Me | 50 |
14 | B | OCH2Ph-3-OMe | 100 |
15 | B | OCH2Ph-2-F | 100 |
16 | B | OCH2Ph-4-F | 2 |
17 | B | OCH2Ph-3-CN | 70 |
18 | B | OCH2Ph-4-CN | 10 |
19 | B | OCH2-4-pyridyl | 53 |
20 | B | NHEt | 50 |
21 | B | 55 | |
22 | B | NHCH2Ph | 43 |
23 | B | NHCH2-4-pyridyl | 3 |
24a24 | B | COXR3 = CN | 87 |
24b | B | COXR3 = CO2H | 65 |
Inhibition determined from ADP Quest assay with 30 μM of inhibitor using aPKCζ (500 ng/ml). Values are the mean of at least n≥5 and were repeated in independent experiments. Standard error of the mean <20%. The experimental conditions are reported in the Supplementary Material.
Str. = chemical structure.